Table 1.
Characteristics * | Cases (n = 20) | Controls (n = 20) |
---|---|---|
Age (years) | ||
Mean ± SD | 50.9 ± 8.1 | 51.1 ± 8.4 |
Median [range] | 51.5 [33.0–67.0] | 51.0 [33.0–69.0] |
Postmenopausal | 12 (60%) | 12 (60%) |
Family history of breast cancer (yes) | 15 (75%) | 15 (75%) |
Parity (yes) | 11 (55%) | 15 (75%) |
Age at first pregnancy (years) | ||
Mean ± SD | 25.0 ± 3.2 | 27.0 ± 6.2 |
Median [range] | 24.0 [21.0–31.0] | 26.0 [19.0–40.0] |
Breastfeeding (yes) | 6 (30%) | 7 (35%) |
Ever smokers | 12 (60%) | 7 (35%) |
Alcohol consumption (yes) | 14 (70%) | 11 (55%) |
Body mass index (kg/m2) | ||
Mean ± SD | 25.3 ± 5.5 | 23.2 ±3.5 |
Median [range] | 23.6 [16.3–41.0] | 22.0 [18.7–32.9] |
Histologic type | ||
Ductal, invasive | 19 (95%) | 19 (95%) |
Lobular, invasive | 1 (5%) | 1 (5%) |
Positive lymph nodes | ||
0 | 12 (60%) | 12 (60%) |
1–3 | 6 (30%) | 6 (30%) |
≥4 | 2 (10%) | 2 (10%) |
Grade | ||
1 | 8 (40%) | 3 (15%) |
2 | 9 (45%) | 10 (50%) |
3 | 1 (5%) | 6 (30%) |
Stage | ||
I | 8 (40%) | 8 (40%) |
II | 11 (55%) | 9 (45%) |
III | 1 (5%) | 3 (15%) |
ER status | ||
Negative | 0 | 0 |
Positive | 20 (100%) | 20 (100%) |
HER2 status | ||
No evaluation | 4 (20%) | 4 (20%) |
Negative | 15 (75%) | 15 (75%) |
Positive | 1 (5%) | 1 (5%) |
Chemotherapy | 14 (70%) | 14 (70%) |
Radiotherapy | 18 (90%) | 16 (80%) |
Hormone therapy | 20 (100%) | 20 (100%) |
* at time of diagnosis of the primary breast cancer; n = number; SD—standard deviation.